Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

November 18, 2021

Congratulations to Dani on the Helen Hay Whitney fellowship!

Dani received the Helen Hay Whitney Fellowship The Helen Hay Whitney Foundation and her research goals are to develop new technologies that advance our understanding...

September 8, 2021

Congratulations to Mandy!

Congratulations to Mandy and team for winning the audience vote at the ETH 3Pi Pitch Competition, where ETH Pioneer Fellows pitched their projects to an audience...

September 1, 2021

Lab retreat in Zermatt

Our lab retreat for 2021 was held in Zermatt, in view of the Matterhorn. We spent the first day doing extemporaneous speed talks (3 minutes maximum!) and discussing...

News Archive

Tweets